About Thomas Collet
Form D filings for Bilayer Therapeutics from 2021 to 2023 list Thomas Collet as president and director.
Thomas Collet first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Collet in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Collet works with at each company, as listed on that company's latest Form D.
Bilayer Therapeutics, Inc. · Form D, Aug 4, 2023
JK
Joshua Korzenik
Director
RL
Robert Langer
Director
HC
Huang Yen-Chen
Director
DZ
David Zhu
Director
CT
Carlo Traverso
Director